Deputy Director of State Owned Enterprise «The State Expert Center of the Ministry of Health of Ukraine» on clinical questions
PhD, 60 published works. 2014 – participated in EU GCP Inspectors Working Group Workshops, 2015 - completed of On-line EU GCP Inspectors Basic Training Course
Professional orientation activities: examination of materials preclinical and clinical studies, project development regulations
Inna Shatova has been working in the Ministry of economic development and trade of Ukraine on the position of Deputy Director of industrial property department, the Head of industrial property law unit.
Inna Shatova, the highly qualified professional in intellectual property, has more than 20 years of working experience in this sphere. Before the abolition of the State service of intellectual property, she occupied the position of Deputy Director of the industrial property department, the Head of industrial property unit of the Service.
Inna graduated Kyiv polytechnic institute with bachelor degree in chemical engineering and Interregional academy of personnel management with master degree in juridical sciences as well as she obtained special education in intellectual property.
Inna Shatova is occupied in development of legislation in the sphere of industrial property, administrative protection of intellectual property rights, fulfilment of the Ukrainian obligations under international treaties etc.
Inna is also Member and Deputy Head of the Appeals Chamber under the Ministry of economic development and trade.
Volodymyr Kostiuk was appointed the Acting Executive Director in March 2018. Before that, he had held the position of the Operations Director of the company since June 2015. Before that, he was the chief of the liquid and semisolid medicinal products manufacturing shop. He has worked in the Company since 2008.
Volodymyr Kostiuk worked on establishing contacts with foreign partners and development of pharmaceutical enterprise’s international cooperation. He participated in clinical trials of preparations manufactured by Farmak in Europe, Canada and the US. Volodymyr Kostiuk headed the team in charge of the operation of SAP ERP, a business automation system, and was responsible for internal audits in the company.
Volodymyr Kostiuk is responsible for development and implementation of the company strategy in manufacturing operations, introduction of efficient business processes into production, management of production activities of the enterprise and processes of development and expansion of production.
In 2009, he graduated from Taras Shevchenko National University of Kyiv with a degree in Economic Cybernetics. He studied at Donau Universitat Krems (Austria) under the MBA program.
Now he is studying at National University of Pharmacy, Kharkiv to obtain a degree in Pharmaceutical Engineering.
Dmytro Shymkiv, the entrepreneur and top manager in the sphere of innovations with 20 years of working experience in leadership positions in Ukraine, Europe and USA. In 1998-2007, he led IT companies and international team of software developers. In 2007, he started his career in Microsoft Ukraine. In 2009-2014, he worked as Microsoft Representative in Ukraine. From July 2014 until August 2018, he took the position of Deputy Head of the Presidential Administration of Ukraine. He was involved in creation of the National Reforms Council, in preparation of the strategy “Ukraine 2020”, in launching 3G/4G mobile communication, in creation of Digital Ukraine and Go Global initiatives, Public Electronic Procurement System ProZorro and Ukrainian Cultural Fund, in providing cyber defense of the Presidential Administration, as well as in implementation of other reforms, initiatives and innovations.
Vitaliy has been working as a Country Manager in AbbVie Biopharmaceuticals GmbH for 5 years. He also worked for such companies as Abbott Ukraine Ltd., Janssen-Cilag, KRKA.
Vitaliy has a successful experience in managing sales and marketing teams in international pharmaceutical companies. He has a wide business connection in the field of pharmaceutical market (Ukraine and Moldova). Competent in marketing, sales, conducting negotiations and managing different organizations, teams and projects.
Vitaliy is a member of the following organisations:
APRaD (Association of Pharmaceutical Research and development): BoD
Chairman of the Board
ACC (American Chamber of Commerce) Co-chair of HC committee since 2013
USUBC (US-Ukraine business council) BoD member since 2008
Dr Crawley is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) in Brussels, Belgium and a World Health Organization (WHO) Expert in ethics. Responsible for the coordination of the Strategic Initiative for the Developing Capacity in Ethical Review (SIDCER). He is a philosopher specialising in legal, regulatory and ethical issues concerning medical research, teaching at several European Universities. He is the past Secretary General, Ethics Officer and Chairman of the Ethics Working Party at the European Forum for Good Clinical Practice (EFGCP) where he also was the editor of the EFGCP news. He is currently Chairman of the Ethical Review Committee of the International Network for the Cancer Treatment and Research Association (INCTRA). He has been a member of the EMVI-AMVTN Ethical Review Committee, a permanent liaison to the International Bioethics Committee of UNESCO.
Dr Oleksandr Gorbenko is an expert in public health, patient advocacy and engagement with overall 18 years experience in pharma. He graduated as a medical doctor (general practice) in O.Bogomolets National Medical University and Shupyk National Medical Academy of Postgraduate Education and later worked on his PhD dissertation in the Ukrainian Institute of Public Health MOH. His experience across pharma includes several medical and commercial roles in representative offices of big biopharma companies (Nycomed/Takeda, Richter Gedeon, GSK) as well as senior global medical roles at GSK and ViiV Healthcare headquarters in the UK. He has an additional experience with UN/UNFPA on women empowerment and combating gender-based violence. Over the last 5 years Dr Gorbenko has been developing necessary capacities/capabilities within corporate patient affairs focusing on getting insights, advice and information from patients throughout the Medicine Development Continuum and disease continuum/individual experience, collaboration with patient organisations, substantiation and inclusion of the specific PRO/PCO measurements, KPIs and standards of patient centricity for big pharma and other programmes. ViiV Healthcare has been broadly recognised as a truly patient-centric company (Number 1 amongst 47 biopharma companies over the last 5 years by PatientView Corporate Reputation Ranking) and reliable partner of HIV community.
Rajeev Gupta was born in India on 18.04.1970.
In 1988, he came to Ukraine to study engineering. In 1994, he graduated from the Kyiv Polytechnic Institute.
In 1995, he began working in the pharmaceutical industry, having established a distribution company specializing in the supply of Indian pharmaceutical products to Ukraine.
In 2001, the company “Gladpharm LTD”, headed by Rajeev Gupta, was among ten largest pharmaceutical distributors in Ukraine.
Since 2002, Rajeev Gupta began to market the medicinal products under his own brands. The medicinal products were manufactured on a contractual basis in India. After successful launching of more than a dozen drugs on the market Rajeev Gupta decided to create his own drug manufacturing.
In 2005, the construction of Kusum Healthcare Pvt Ltd pharmaceutical plant began in India, and since 2007, most of the company’s medicinal products are manufactured at its own plant. Given the importance of the Ukrainian market for the company, in 2005 a decision was made to build a pharmaceutical plant in Ukraine.
In August 2009, “Kusum Pharm” plant was put into operation in Sumy. Both plants of the company are constructed in accordance with GMP standards.
The products manufactured by Kusum group of companies are sold in Ukraine, India, Kazakhstan, Uzbekistan, Moldova, Philippines, and Myanmar.
Kusum group of companies is included in the TOP 11 pharmaceutical companies of Ukraine, and is recognized to be one of the most rapidly growing companies in the pharmaceutical industry.
Deepak Sharma is Director of Glenmark Ukraine, belonging to Glenmark Pharmaceuticals Ltd., an International pharma company with presence over 80 countries. Glenmark Pharma Ranks among top 80 Pharma & Biotech companies globally. (SCRIP 100 Rankings 2017). Glenmark pharma has 17 manufacturing facilities across US, India, Czech Republic, Argentina and Switzerland.
In addition to Ukraine, Deepak is also looking after Moldova, Georgia and Azerbaijan. In this role, Deepak is responsible for overall operations of the organization.
Deepak has an experience of apprx 15 years in Pharma industry, he has worked in different organizations like Cipla, Pfizer, Ranbaxy & Macleods on different positions. He is based in Ukraine from last 7 years and travelled extensively inside the region including, Ukraine , Kazak, Uzbek, Georgia, Azerbaijan and Moldova. He possesses a good knowledge of the pharma industry in the region. He has a vision to develop the pharma marketing more interesting and innovative. He is instrumental in many of the ongoing CSR projects in the region.
Deepak holds a Management degree, in addition to the life-sciences degree. Deepak has spoken on various issues on various platform related to pharma Industry. He is often invited by management colleges for talk to inspire students. In the recent past , Deepak was interviewed by Pharmaboard room and Medicinman. His interview on his career was published in Medicinman last year.
Deepak lives in Kyiv with wife and 2 children.
Head Laboratory and Clinical Practices (GLP, GCP) Audit Office of The State Expert Center of the Ministry of Health of Ukraine
65 published works, More than 450 Inspections (clinical audits) of Clinical Trials in Ukraine (participated in FDA-, EMA- and PMDA-inspections). 2014-2016 - completed Research Ethics program offered by The University of Vilnius and The Bioethics Program of Clarkson University. 2014, 2016, 2017, 2018 – participated in EU GCP Inspectors Working Group Workshops, 2015 - completed On-line EU GCP Inspectors Basic Training Course
Professional orientation activities: inspection of clinical trials, ethical issues of clinical trials conducting, project development regulations
Volodymyr Ignatov is the Head of IPSEN Pharma country office in Ukraine and Moldova.
Volodymyr Ignatov has more than 20 years of experience in Ukrainian pharmaceutical market as a Head of country office of the companies Rhone-Poulenc Rorer (1993-1999), Aventis (2000-2005), Astra Zeneca (2005-2009) and IPSEN.
In 2001-2009, he was actively engaged in work of the European Business Association (EBA) as Vice President (2004-2005), Head of European pharmaceutical manufacturers group by the EBA Health Care Committee.
Since 2010, he has been working as Executive Director in AIPM Ukraine.
Bogomolets National Medical University in Kyiv, Candidate of medical sciences, MBA.
Borys Labenskyi has joined STADA in July 2019 as General Manager for Ukraine.
Earlier he was a Country Head at Sandoz and Country President at Novartis group in Ukraine.
On pharmaceutical market he also had held positions of Country Manager at Johnson & Johnson and Sales Director at GlaxoSmithKline.
Overall Borys has almost 30 years of experience in various roles within the pharmaceutical, FMCG and domestic appliances industries in Ukraine, Moldova and Russia.
Irina Karakai has more than 20 years of business experience in pharmaceutical market in Ukraine, in general management, leading the organizations as Country/Region Head in several international companies: Novartis, Boehringer Ingelheim, Jadran Galenski Laboratorij.
Besides Ukraine, during last 15 years she is being involved in development of business in various other CIS countries
Irina Karakai holds a degree in Medicine from the University of Lugansk, PhD in Marketing from the University of Kiev and MBA degree from University of Pittsburgh’ Joseph M.Katz Graduate School of Business.
Has broad experience in building and structuring the organizations, market access, sales & marketing, HR, development of personal, Supply Chain management, building the cross-functional cooperation, project management, etc.
She started her career in 2008 as a junior specialist in Samsung Electronics rising to the position of cluster digital lead for Ukraine, Caucasus, Central Asia and Nordic markets in Pfizer.
She created and implemented a number of development strategies in digital sphere. She launched from scratch and relaunched more than 30 web sites, applications for doctors and users on different markets. She has the diversified experience starting from the launch of Bada OS operating system and development of initial applications for the Ukrainian market and rising to the development of interactive materials to support the holding of medical conferences, launching and optimizing promo companies in Google and Facebook and so on.
Since 2013, she started her career in pharmaceutical business in MSD, where she is engaged in implementation of new tactics, harmonization of traditional and digital marketing, supporting new methods of work and creating innovative approach to communication with target audiences.
She is a digital enthusiast in pharmaceutical business.
Maryna Buchma is Government Affairs Director at Teva Ukraine pharmaceutical company, Co-chair of the Healthcare Committee at American Chamber of Commerce in Ukraine, and advocate for healthcare reform. Maryna has broad experience in corporate affairs, public relations, social responsibility and strategic communications in pharmaceutical and non-profit sectors. Prior to joining Teva in 2016, Maryna worked at GSK, European Business Association, Renaissance International Fund.
Since February 2019, Oresta Piniazhko has been appointed on the position of Director of Health Technology Assessment (HTA) Department at the SEC of the Ministry of Health of Ukraine, ensuring the implementation of the best international practices on HTA into the health care system of Ukraine.
Since 2017, Oresta holds a position of President of ISPOR Ukraine Chapter.
Oresta's professional experience covers various fields of activity: specialist in the pharmaceutical industry (2012-2015), senior lecturer with a Ph.D. degree (2017) at Danylo Halytsky Lviv National Medical University, member of the Expert Committee on Selection and Use of Essential Medicines Ukraine (2016-2019).
Alla has been woring as a Director of Medical and Regulatory Affairs department, PV, QA Ukraine and CIS in Acino Pharma AG, Pharma Start LLC Ukraine since 2015. From 2003 to 2015 she was a medical representaive to RA, Medical, PV, QA Director in group of countries at Nycomed (Switzerland), Takeda Pharmaceutical (Japan). Alla graduated as a MD from National Medical University (Ukraine, Kiev) in 2003. Alla has a PhD in Pediatrics.
Valentyn Chernyshov MD, PhD in medicine, has been working in AbbVie since 2013. In April 2019 he was appointed the Market Access Manager Ukraine. Earlier he held the position of Customer Excellence Manager Ukraine and managed different CIS Medical Affairs roles with locations in Kyiv (Ukraine) and Minsk (Belarus). Before joining AbbVie, he was a Senior Lecturer in the Anesthesiology Department, Ukrainian Military Medical Academy.
During his pharmaceutical career, Valentyn executed leadership in a range of scientific and educational projects (CEE, CIS, Ukraine, Belarus), developed and conducted trainings for HCP and employees, acted as Publication Lead for international clinical trials etc. He also led the implementation of Brand and IFT-excellence strategy in Ukraine.
Current Valentyn’s responsibility is chairing the strategic projects aimed at easing of access for Ukrainian patients to innovative treatment. HTA, Managed Entry Agreements and IPR protection are within his professional interest.
Valentyn is a co-author of textbook and author of several scientific publications. He is MBA student in Kyiv School of Economics (KSE).
Dr Szczukiewicz is a clinical research professional with broad CRO and pharmaceutical experience concerning all phases of clinical trials. Currently responsible for management of Central & Eastern European region in regards to projects set up, execution, oversight and reporting, providing local strategic planning and organisation to achieve successful studies completion. Since 2016 Dr Szczukiewicz has been a Member of the Board and Chairman of the Training Group at Association for Good Clinical Practice in Poland (the biggest professional non-profit organization in Poland).
Piotr Iwanowski is an Assoc. VP Clinical Research Europe at Wockhadt Bio AG, as well as national board member of Polish Association for Good Clinical Practice (GCPpl).Within the GCPpl Association he is the head of the standing working group on ethics review of clinical trials. His particular interest are clinical studies in special populations (emergency trials, patients not mentally competent to consent, paediatric trials); he had also published in that domain.
In the past he had organized a large international conference in Poland dedicated to biomedical research in emergency settings.
In his home country Piotr is leading the lobbying activities towards the ethics committees and the regulator with regards to establishing a new system for ethics review of clinical trials in view of the forthcoming applicability of the EU Clinical Trial Regulation.
Piotr has been speaking at multiple international and national conferences dedicated to clinical trials; he is also a lecturer at two postgraduate study programmes at Warsaw universities.
Victoria Sopilnyak is an experienced lawyer with 18 years of experience in providing legal services in the field of intellectual property rights protection. Since 2010, Victoria has been a partner of Dubinsky and Osharova.
In her practice, Victoria focuses on litigation in the field of protection of intellectual property rights of pharmaceutical and healthcare companies. In addition, Victoria specializes in copyright, well-known trademark recognition, patents, domain name disputes, and more. The names of her clients are known all over the world.
According to numerous international and Ukrainian rankings such as Legal 500 EMEA, Chambers Global, Best lawyers, World Trademark Review, IP Stars, IAM Patent 1000: The World’s Leading Patent Professionals, Top 50 Law Firms in Ukraine, Ukrainian Law Firms. A Handbook for foreign clients, TOP 100 Best Lawyers. Client's Choice, Victoria is a highly recommended expert in the area of Intellectual Property in Ukraine, the first-choice attorney for life science and pharmaceutical disputes, trademark, patent and industrial design litigation, copyright cases, recognition of trademarks as well-known. Names of her clients are well-known all over the world.
Victoria is a member of International Trademark Association (INTA), International Association for the Protection of Intellectual Property (AIPPI), Ukrainian Bar Association. Victoria is also an active participant in many public organizations, namely: the Ukrainian Bar Association; European Business Association; American Chamber of Commerce and Ukraine, Ukrainian Association of Trademark Owners. She is actively involved in various conferences, roundtables and seminars as a speaker and moderator, besides she is working on improving Ukrainian legislation.
Nataliia graduated from Vinnytsya National Pyrogov Memorial Medical University in 2000 and internship in neurology in 2002.
After three years work in neurology, she continued her career in pharmaceutical business, starting from the position of field officer and medical representative and reaching the position of key client relations manager. She cooperated with HCPs mainly in oncology, diabetes, orphan and cardiovascular diseases.
She worked with global manufacturers like Pfizer, Sanofi and Rosche. She has more than six years’ experience in access of innovative medicines to the Ukrainian market.
Since 2017, she is active member of ISPOR Ukrainian chamber.
Daria graduated from Kyiv National University of Trade and Economics, with MA degree in Finance and Credit as Financial analyst. She has a degree in Commercial Law from Kyiv National University of Trade and Economics, in Law from Vadym Getman Kyiv National Economic University.
Legal career of D. Bondarenko began in the Kyiv City Clinical Hospital No. 1 of the Main Health Department of the Kyiv City State Council (KCSC) as a lawyer of the special fund health insurance department.
At the same time, Daria Bondarenko was an assistant-consultant of the deputy head of Main Health Department of the KCSC (now KCSC Health Department).
By the decision of AMOMD founders general meeting D. Bondarenko was elected at Nov. 7, 2012 to the position of Executive Director and combined this work in Nov. 2014 with a legal practice in leading law company “Legal Alliance”.
According to Association Article the Executive Director represents AMOMD in relations with central and local authorities, other state and non-governmental Ukrainian, foreign and international organizations, enterprises, individuals and acts on behalf of the Association.
Implemented projects with D. Bondarenko participation:
• Draft Law No. 3180 “On the amendments to the item 193.1 “в” of article 193 of the Tax Code of Ukraine” dated by Sep. 25, 2015;
• Cabinet of Ministers Resolution No. 181 “On the amendments of certain CMR decrees” dated by May 27, 2014;
• Cabinet of Ministers Resolution No. 215 “On the amendments of certain CMR decrees” dated by July 01, 2014;
• Cabinet of Ministers Resolution No. 216 “On approval of medical devices, which operations for delivery in the customs territory of Ukraine and importation into the customs territory of Ukraine are to be taxable for VAT at the rate of 7 percents” dated by July 01, 2014;
• Cabinet of Ministers Resolution No. 240 “On the amendments of certain CMR decrees” dated by March 23, 2016;
• Cabinet of Ministers Resolution No. 501 “On Amendments to the CMR reglament (in respect of changes to item 2 of paragraph 40 for Chapter 3)” dated by Aug. 08, 2016;
• Cabinet of Ministers Resolution No. 43 ‘On Amendments to the CMR order of Oct. 17, 2008, No. 955 and to the CMR order of Jul. 02, 2014, No. 240” dated by January 25, 2017 – regarding the cancellation of change declaring of the wholesale-sale price for medical devices;
• MHU order No. 660 “On the recognition of the MHU order of Dec. 29, 2011, No. 1000, as invalid one” dated by Oct. 09, 2015;
• MHU order No.361 “On amending the MHU order of July 16, 2012 No. 533” dated by April 13, 2016.
Pharmaceutic regulation, legal regulation of medical devices legalization, price control and VAT taxation of medical devices, technical regulation of medical devices, regulatory activity
• working group of Ministry of Economic Development and Trade of Ukraine on improving the assessment of compliance of legislatively regulated measuring instruments used to ensure the protection of citizens life and health;
• working group on the legislation improvement in the sphere of medicinal products circulation of the Ministry of Health of Ukraine;
• community council attached to AMCU;
• Ukrainian Bar Association (UBA)
Yuliya Shchehlova, graduated from Kharkov Pharmaceutical Academy with Pharmacists Diploma. She also has a 'Marketing degree' from National Pharmaceutical University of Management & Economy, Kharkov
Before her role as a Senior Product Manager in the Representative Office Takeda, Ukraine
Yuliya used to be a Product Manager in the Representative office of Mepha in Ukraine.
SUR Sergii (24.07.1961, Zaporozhie, Ukraine) — Candidate of Chemical Sciences (1988), Doctor of Pharmaceutical Sciences (2005), Director of "ARTERIUM LTD." (2018).
Education: Zaporozhie State Medical Institute, Pharmaceutical Faculty (1983), Postgraduate studentship of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences, Kiev (1988)
· Deputy Head of the Central District Pharmacy in Berezovka city, Odessa region (1983);
· Post graduate student (1985), scientific associate (1989) of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences;
· Scientific associate in Scientific Hygienic Center, Ukrainian Academy of Medical Sciences (1992);
· Head of State Laboratory for Quality Control of Medicines, Institute of Pharmacology and Toxicology, Ukrainian Academy of Medical Sciences (1993),
· Director of Central Laboratory for Quality Control of Medicines, MoH of Ukraine (1998),
· Deputy Chief Inspector of Ukraine for Quality Control of Medicines, MoH of Ukraine (2000),
· Director of Research and Development of "Arterium" Corporation (2005), Regulatory Affairs Director of "Arterium" Corporation (2013)
· Director of "ARTERIUM LTD." (2018).
Role and Duties:
Developing and submission of functional strategy in R&D, RA
Development and implementation of R&D and RA business processes and structure
Research, development and marketing authorization of new products on all markets
Member of Company Directors Board
Nataliia Dekhno graduated from Т. Shevchenko Kyiv National University with Master’s degree in Economics in 2006.
She has 6 years’ experience in marketing in FMCG sphere with such international companies as METRO C&C and Henkel and 7 years of independent brand management experience in OTC pharmaceutics. As professional marketeer she has deep knowledge of Pharmaceutical industry in Ukraine and proved track of records in different categories.
In 2015 Nataliia graduated from Netherlands Institute of Marketing; she has complied with EMC Qualifications Framework Standards and therefore was recognized as Marketing Manager.
In her current position as Business Development Manager in GSK Consumer Health she is responsible for implementation of business development and market access initiatives in UA&CIS, such as big country or category or brand growth and project management initiatives to drive simplification agenda. In parallel she manages local NPI & Artwork team and artwork process. Nataliia is responsible for integration to Eurasian Economic Union for all countries including Russia.
Senior Technical Advisor for Pharmaceutical Policy and Governance of SAFEMed.
While working full time, Dr. Rabia continues to remain as one of the Directors of International Health Technology Assessment Society (HTAi), the past-Chair and steering committee member of HTAi Developing Countries Interest Group with members in over 50 countries, Chair of the HTAi Medical Devices Interest Group and the Chair of Eurasian HTA Initiative with institutional members from 9 countries. Prior to her position in SAFEMed, she was the Director of a Hospital-based HTA Center in Turkey that covered HTA, innovation for medical devices and real world evidence. In Turkey, she also served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during transition to universal health coverage and was one of the co-authors of the reimbursement guidelines; the National Clinical Quality Coordinator of the Turkish MoH with the coordinating task of all activities around HTA, clinical guidelines, quality and performance-based payment; and the President of Turkish Evidence-Based Medicine Society. She is a family physician by background with additional trainings in Italy, Spain, Canada, and the USA. In addition to her advisory roles to Turkish Health Care Institutes, the Turkish MoH and several national and international NGOs, she is also recognized as an editor of eight books and the author of more than 150 articles.
Ivan Vyshnyvetskyy graduated Donetsk State Medical University in 2001
with the master and PhD degree in therapy. Until 2014, he worked as
an Associate Professor in the department of internal diseases and Chief
of clinical research management section of this University.
In 2015, he started his career in Zhytomyr city central hospital as a Head
of division on clinical research. At the same time he is Associate Professor
in the department of health management in the Bogomolets National Medical
University and starting from 2018 - Head of Ukrainian Association for Clinical Research.
Kostyantyn Kosyachenko, the President of “Ukrainian agency of health technology assessment”, the Head of the department on pharmaceutical management and economy in Bogomolets national medical university, Doctor of pharmaceutical science, Professor, Honored worker of Ukrainian pharmacy.
Mr. Kosyachenko was born on the 10 September 1071 in Kropyvnytsky. In 1993, he graduated Zaporizhzhia state medical university. He started his professional career as a pharmacy manager in Kropyvnytsky region and then he was invited to work in the Zaporizhzhia state medical university. In 1998, he was awarded with the scientific degree of Candidate in pharmacy. Since 1999, he held several senior positions in the Ministry of health and Presidential Administration in the field of medicine quality control. At the same time, he gave lectures in National university of pharmacy in Kharkiv, Shupyk national medical academy of postgraduate education. In 2012, he received the degree of Doctor in pharmacy with the academic work in the field of health technology assessment. He is engaged in price formation on medicines, implementation of health technology assessment.
He worked also as a Deputy chief inspector on medicine quality control, Principal specialist in the Ministry of health in the field of pharmacy management, Editor-in-chief in the magazine “Health technology assessment”. In 2007, he received the title “Honored worker in pharmacy” by presidential decree.
Sergey has more than 15 years’ experience within international Pharma companies as different Commercial and Commercial Excellence roles with area of responsibilities Ukraine and CIS region. He has join Proxima Research International in March 2019 as a Country Head and now he is in charge of all commercial related processes of the company in Ukraine.
Sergey Goryslavets has been working at Glenmark Ukraine on Sales & Marketing Director position for 2,5 years, being responsible for strategic product portfolio development, SF development, short-term and long-term planning, managing team of professionals in marketing and sales areas. Totally, Sergey has over 20 years’ experience in pharmaceutical industry, starting from medical representative position up to his current role. His professional career have been lasting in number of original and generic pharmaceutical companies, dealing with various products. In 1997 Sergey graduated as a pharmacist from Zaporozhye State Medical University, holds master’s degree in economics from Kiev National Economic University (2003).
Andriy Volokha has been working in GSK for eleven years and has great experience in managing sales and dental detailing teams. He was appointed as the Marketing Director for Ukraine and CIS in March 2019. Before that, he had held the position of the Expert and Sales Force Manager since January 2018.
In his new role he has already achieved great results: GSK has become the fastest growing company OTC in Ukraine and Kazakhstan according to June’s YTD.
Andriy got master’s degree in Surgery in 2012.
He also successfully completed Coaching for effective leaders in 2015 and Business and Finance acumen in 2017.
Since March 2019, Andriy has been working closely with ACC.
Warehouse and Distribution Lead for Cluster of 9 markets; Ukraine, Russia, Belarus, Kazakhstan, Uzbekistan, Moldova, Georgia, Armenia, Azerbaijan.
Expert in Operations and Supply Chain business process management, Integrated Business planning; operational process re-design and end-two-end Supply Chain transformations.
While working full time, Margarita is permanent visit professor at MIM Business school for MBA/pre-MBA program . Regular speaker at international and national Pharma, Supply Chain and Finance conferences.
She hold the current position in GSK pharmaceutical since 2016th till present. Prior to her position she held the role as Country board Supply Chain and Quality Director at Danone ELN ( Nutricia); Country SCM in ABB , and other senior roles within P&G and Colgate.
Margarita hold MBA, MIM with Graduate Business Internship in Tepper School of Business at Carnegie Mellon University in 2009 and APICS CSCP certification, 2019 ( Certified Supply Chain Professional, USA)
Iliyan Panchev has built his considerable expertise in the pharmaceutical track and trace technologies field since 2014, having been actively involved in the sales and business development of pharmaceutical serialization, aggregation and track & trace solutions at all levels. He is one of the first experts who introduced the track and trace technologies to the pharma industry in the Balkans.
From 2012 to 2016, he was the sales director of the leading track and trace solutions provider in Bulgaria. In 2017, Iliyan joined Visiopharma Technologies as their sales and marketing director. in October 2019 he was appointed as an International Business Manager of VISIOTT Technologie – a sister company of AGE Bilisim - the leading track and trace solutions provider in Turkey.
Iliyan has visited clients and partners in 23 countries and participated in track and trace projects for products sold on the European, US, Chinese, Russian and MENA markets. He has negotiated with customers the technical and commercial parameters of almost any type of solutions for serialization and/or aggregation of vaccines, eye-drops, tables, ointments, hdpe bottles and glass vials including software integrations between on-premise and cloud-based serialization systems, ERP, WMS, and regulatory systems at levels L2, L3, L4 and L5. Iliyan’s customers include marketing authorisation holders, contract manufacturing organizations, contract packaging organizations, third-party logistics, parallel importers and wholesalers.
His high-impact presentations at tradeshows, conferences and business meetings include manual, semi-automatic and fully automatic standalone serialization and tamper evidence stations, multi-level aggregation stations (for bundles, cases and pallets), reworking stations, checkweighers, bottle serialization and pre-aggregation stations.
Iliyan has a Master’s degree in Management Information Systems from Sofia University St. Kliment Ohridski, and a Bachelor’s degree in Economics Management from Veliko Tarnovo University St. Cyril and St. Methodius.
Starting from July 2017 Vladimir Shtepa is working for BaDM LLC in the position of Deputy Commercial Officer on marketing ensuring the development and rendering of services on promotion of pharmaceutical products from the manufacturer to the ultimate consumer.
Vladimir has more than 18 years of experience in marketing and management of sales in the pharmaceutical field. In 1999 he started his professional career as a sales manager in Kiev-based Company “Vipex-Pharm” and shortly he was promoted to the position of administrative director of the regional branch.
From 2002 till 2008 he was engaged in the development of retail sales to the pharmacies and healthcare facilities as the representative of BaDM LLC. In 2009 Vladimir was appointed to the position of the Head of sales division responsible for logistics, distribution, and promotion of pharmaceutical products in the South-Eastern region.
Vladimir obtained his doctoral degree in medicine at Zaporizhia State Medical University and also the graduate diploma in marketing and management at Zaporizhzhya National University.
Currently, he lives in Dnipro. He’s married and has two children; in his spare time he enjoys improvisation on the piano, goes in for sports and takes online courses on marketing and market environment.
Alexandra Sologub, MD, MBA, is Director of “Likravy” Ukraine, belonging to the nature network® - the group of companies, managed as a family company in its third generation and operated internationally in more than 60 countries. The nature network® offers a broad spectrum of products and services: from botanicals and their refinement into premium-quality base materials, to laboratory, consultancy and distribution services.
Alexandra has an experience of approximately 20 years in Pharma industry; she has worked in different organizations like GSK, Teva, Darnitsa.
To find out more about speaking opportunities please contact:
Tel: +44 203 9504820